Global /China /Healthcare /Drug Manufacturers - General /600422
chevron_leftBack
KPC Pharmaceuticals,Inc. logo

KPC Pharmaceuticals,Inc.

600422
SSE: 600422 Delayed
9.50CNY 0%
1.40 USD
As of 22 June 2026, KPC Pharmaceuticals,Inc. has a market cap of $1.06B USD, ranking #10389 globally and #2907 in China. It ranks #926 in the Healthcare sector, and #347 in the Drug Manufacturers - General industry.
Global Rank
10389
Country Rank
2907
Sector Rank
926
Industry Rank
347
Key Stats
Market Cap
$1.06BUSD
7.19B CNY
Enterprise Value
$1.29BUSD
8.76B CNY
Revenue (TTM)
$858.74MUSD
5.8B CNY
EBITDA (TTM)
$17.24MUSD
116.67M CNY
Net Income (TTM)
$17.41MUSD
117.67M CNY
EBITDA Margin
2%
Profit Margin
2%
PE Ratio
61.3
Forward PE
22.8
PS Ratio
1.2
PB Ratio
1.1
EV/EBITDA
61.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wei Yan open_in_new
Employees
5,072
Founded
1951
Website
kpc.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -14% -16% -24% -30% -38%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
600422
昆药集团股份有限公司 Class A
ISIN: CNE0000015P8
Shares Out.:
756.976M1 Shares Float: 465.563M2
TV:
SA:
YF:
GF:
BA:
MS:
9.50 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About KPC Pharmaceuticals,Inc.

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as well as engages in the wholesale and retail of medicines and equipment. The company offers products in the field of cardiovascular and cerebrovascular, orthopedics series, antimalarial, gynecology, digestive system, and others treatments. It offers its products under Luotai, Tianxuanqing, Artemedine, Artem, and Arco brands. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals,Inc. was founded in 1951 and is based in Kunming, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$54.0B
364.89B CNY
5K%
44.9
603259
$49.78B
336.36B CNY
5K%
17.2
$28.51B
223.48B HKD
3K%
35.7
$18.8B
147.32B HKD
2K%
162.3
$16.56B
111.89B CNY
1K%
-
9926
$16.01B
125.46B HKD
1K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
71K%
38.1
JNJ
$547.28B
51K%
26.4
ABBV
$360.63B
34K%
97.4
$318.3B
256.25B CHF
30K%
19.9
AZN
$284.64B
215.59B GBP
27K%
27.6
MRK
$274.03B
26K%
15.1
chevron_leftBack